|
TRIO expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76100000004453E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.86649999970257E-07 |
| Normal-vs-Stage2 |
5.465800E-02 |
| Normal-vs-Stage3 |
7.598300E-03 |
| Normal-vs-Stage4 |
4.319200E-03 |
| Stage1-vs-Stage2 |
9.469000E-01 |
| Stage1-vs-Stage3 |
1.507770E-01 |
| Stage1-vs-Stage4 |
6.282000E-01 |
| Stage2-vs-Stage3 |
5.666000E-01 |
| Stage2-vs-Stage4 |
8.588200E-01 |
| Stage3-vs-Stage4 |
5.350000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59057999999934E-05 |
| Normal-vs-AfricanAmerican |
1.503590E-02 |
| Normal-vs-Asian |
5.393900E-02 |
| Caucasian-vs-AfricanAmerican |
9.140600E-01 |
| Caucasian-vs-Asian |
1.158440E-01 |
| AfricanAmerican-vs-Asian |
1.164770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.55350000000355E-05 |
| Normal-vs-Female |
2.06520000001209E-06 |
| Male-vs-Female |
2.135000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.688500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.48169999998993E-05 |
| Normal-vs-Age(61-80Yrs) |
2.34849999999343E-05 |
| Normal-vs-Age(81-100Yrs) |
4.771600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.237200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.431200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.029800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.902000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.826590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.141400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.08609999958243E-07 |
| Normal-vs-Grade 2 |
1.63333999999571E-05 |
| Normal-vs-Grade 3 |
8.644000E-04 |
| Normal-vs-Grade 4 |
5.737900E-03 |
| Grade 1-vs-Grade 2 |
4.021900E-02 |
| Grade 1-vs-Grade 3 |
5.857000E-03 |
| Grade 1-vs-Grade 4 |
4.059800E-02 |
| Grade 2-vs-Grade 3 |
6.037800E-01 |
| Grade 2-vs-Grade 4 |
7.972600E-01 |
| Grade 3-vs-Grade 4 |
5.642600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.83210999999961E-05 |
| Normal-vs-ccB subtype |
2.156300E-04 |
| ccA subtype-vs-ccB subtype |
9.172200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.96160000000601E-05 |
| Normal-vs-N1 |
9.661800E-02 |
| N0-vs-N1 |
7.507400E-01 |
|
|
